The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury
Open accessAbstract
Tissue damage induces cells into reprogramming-like cellular state, which contributes to tissue regeneration. However, whether factors promoting the cell reprogramming favor tissue regeneration remains elusive. Here we identified combination of small chemical compounds including drug cocktails robustly promoting in vitro cell reprogramming. We then administrated the drug cocktails to mice with acute liver injuries induced by partial hepatectomy or toxic treatment. Our results demonstrated that the drug cocktails which promoted cell reprogramming in vitro improved liver regeneration and hepatic function in vivo after acute injuries. The underlying mechanism could be that expression of pluripotent genes activated after injury is further upregulated by drug cocktails. Thus our study offers proof-of-concept evidence that cocktail of clinical compounds improving cell reprogramming favors tissue recovery after acute damages, which is an attractive strategy for regenerative purpose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A drug cocktail of HDACs, GSK-3β, and TGF-β kinase enabled cell reprogramming in vitro, thus improving liver regeneration and function after acute injuries in mice.194”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606 · cited 2×
“…that cell reprogramming efficiency can be enhanced by chemical compounds, even reprogramming factors can be partially or completely replaced by combination of small chemical compounds in pluripotent cell generation (Huangfu et al., 2008; Ichida et al., 2009; Esteban et al., 2010; Hou et al., 2013).”
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515 · cited 2×
“Since inhibitors of HDACs, GSK-3β, and TGF-β kinase have been applied against diseases including cancer and mental illness in clinic (Johnstone, 2002; Avila and Hernández, 2007; Ikushima and Miyazono, 2010), we further accessed the reprogramming-promoting efficiency of pharmaceutical compounds from these pathways.”
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., et al. (2013) · Science · doi:10.1126/science.1239278 · Cited by 1,402 · cited 2×
“…that cell reprogramming efficiency can be enhanced by chemical compounds, even reprogramming factors can be partially or completely replaced by combination of small chemical compounds in pluripotent cell generation (Huangfu et al., 2008; Ichida et al., 2009; Esteban et al., 2010; Hou et al., 2013).”
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
TGFβ signalling: a complex web in cancer progression
Ikushima, H., & Miyazono, K. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2853 · Cited by 1,173 · cited 2×
“Since inhibitors of HDACs, GSK-3β, and TGF-β kinase have been applied against diseases including cancer and mental illness in clinic (Johnstone, 2002; Avila and Hernández, 2007; Ikushima and Miyazono, 2010), we further accessed the reprogramming-promoting efficiency of pharmaceutical compounds from these pathways.”
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988 · cited 1×
“During the preparation of this manuscript, an excellent work by Izpisua Belmonte and colleagues reported partial reprogramming in vivo not only ameliorates signs of aging but also improves regeneration of pancreas and muscle after injury (Ocampo et al., 2016).”
Vitamin C Enhances the Generation of Mouse and Human Induced Pluripotent Stem Cells
Esteban, M. A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., Li, W., Weng, Z., Chen, J., Ni, S., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2009.12.001 · Cited by 872 · cited 2×
“…that cell reprogramming efficiency can be enhanced by chemical compounds, even reprogramming factors can be partially or completely replaced by combination of small chemical compounds in pluripotent cell generation (Huangfu et al., 2008; Ichida et al., 2009; Esteban et al., 2010; Hou et al., 2013).”
A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog
Ichida, J. K., Blanchard, J., Lam, K., Son, E. Y., Chung, J. E., Egli, D., Loh, K. M., Carter, A. C., Di Giorgio, F. P., Koszka, K., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.09.012 · Cited by 808 · cited 2×
“…that cell reprogramming efficiency can be enhanced by chemical compounds, even reprogramming factors can be partially or completely replaced by combination of small chemical compounds in pluripotent cell generation (Huangfu et al., 2008; Ichida et al., 2009; Esteban et al., 2010; Hou et al., 2013).”
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy
Efe, J. A., Hilcove, S., Kim, J., Zhou, H., Ouyang, K., Wang, G., Chen, J., & Ding, S. (2011) · Nature Cell Biology · doi:10.1038/ncb2164 · Cited by 623 · cited 2×
“, 2014), cardiomyocyte (Efe et al., 2011), neural stem cells (Wang et al.”
Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., et al. (2016) · Science · doi:10.1126/science.aaf4445 · Cited by 589 · cited 2×
“It’s also known that these genes involved are key factors to reprogramming cells into pluripotency in vitro and in vivo (Mosteiro et al., 2016).”
Cited by
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stojanović, S. D., Fiedler, J., Bauersachs, J., Thum, T., & Sedding, D. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz919 · Cited by 188
“ase enabled cell reprogramming in vitro, thus improving liver regeneration and function after acute injuries in mice.(194) The authors attributed this effect to the up-regulation of pluripotency genes.”
BackgroundCellular Reprogramming as a Therapeutic Target in Cancer
Xiong, S., Ye, F., & Cheng, L. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.05.001 · Cited by 54
Self-citationChemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
(2025) · doi:10.1038/s44321-025-00265-9 · Cited by 49
“…regeneration in the liver and heart, thus providing proof-of-principle that treatment with these reprogramming-associated chemicals could bene fi t tissue repair and, more recently, enable autologous islet replacement in type 1 diabetes (Tang and Cheng, 2017; Huang et al, 2018; Wang et al, 2024).”
Toward a Unified Theory of Aging and Regeneration
West, M. D., Sternberg, H., Labat, I., Janus, J., Chapman, K. B., Malik, N. N., de Grey, A. D. N. J., & Larocca, D. (2019) · Regenerative Medicine · doi:10.2217/rme-2019-0062 · Cited by 50
Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology
Paine, P., Nguyen, A. T., & Ocampo, A. (2023) · Aging Cell · doi:10.1111/acel.14039 · Cited by 43
“For these reasons, chemical induced partial reprogramming (ciPR) could be a particularly intriguing method of IVPR, especially if combined with prodrug targeting strategies such as antibody directed enzyme prodrug therapy (ADEPT; Sharma & Bagshawe, 2017; Tang & Cheng, 2017).”
Method
Metadata
- Authors
- Tang, Y., & Cheng, L.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Cheng, Lin
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-11
- Volume
- 8
- Issue
- 4
- Pages
- 273-283
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- PMC
- PMC5359186
- OpenAlex
- W2587087824
- Cited by
- 22
- References
- 45
- Citations by year
- 2026: 3 · 2025: 4 · 2023: 2 · 2022: 5 · 2021: 2 · 2019: 4 · 2018: 2
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Protein & Cell (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Natural Science Foundation of Shanghai
- Second Military Medical University
- Shanghai Rising-Star Program (16QA1402800)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- cellular reprogramming, drug mixtures, liver regeneration, acute liver injury, partial hepatectomy, hepatotoxicity, tissue regeneration, chemical compounds
- MeSH terms
- Cellular Reprogramming Techniques, Animals, Mice, Induced Pluripotent Stem Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury. https://app.cochat.ai/papers/10.1007/s13238-017-0373-y
- The paper
- Tang, Y., & Cheng, L. (2017). Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury. Protein & Cell. https://doi.org/10.1007/s13238-017-0373-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.